Venn Life Sciences Holdings Stock CINNOBER BOAT
Stocks
VENN
GB00B9275X97
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 51.53M 68.75M 60.38M 56.15M 96.81M 6.62B 98.31M 667M 261M 3.25B 258M 253M 11.25B | P/E 2026 * |
-15.1x | P/E 2027 * | -114x |
|---|---|---|---|---|---|
| Enterprise Value | 43.03M 57.42M 50.43M 46.9M 80.86M 5.53B 82.1M 557M 218M 2.72B 216M 211M 9.4B | EV / Sales 2026 * |
0.85x | EV / Sales 2027 * | 0.75x |
| Free-Float |
96.84% | Yield 2026 * |
0.43% | Yield 2027 * | 1.08% |
Last Transcript: Venn Life Sciences Holdings
| Manager | Title | Age | Since |
|---|---|---|---|
Yamin Khan
CEO | Chief Executive Officer | 57 | 2022-02-23 |
Ian O'Connell
PRN | Corporate Officer/Principal | 39 | 2017-06-30 |
| Director of Finance/CFO | 63 | 2022-10-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Elaine Sullivan
CHM | Chairman | 65 | 2025-06-04 |
Yamin Khan
BRD | Director/Board Member | 57 | 2021-10-12 |
| Director/Board Member | 63 | 2022-10-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 68.75M | |
| +1.17% | -1.84% | -1.88% | +10.61% | 46.86B | |
| +0.25% | +1.65% | +399.22% | +647.65% | 40.23B | |
| -0.27% | +4.45% | +11.81% | +60.81% | 36.23B | |
| +0.35% | +0.87% | +4.46% | -10.31% | 34.72B | |
| +3.14% | +1.02% | +4.76% | +43.00% | 27.89B | |
| -0.73% | +11.84% | +34.39% | +134.44% | 16.79B | |
| +0.47% | -2.74% | - | - | 16.74B | |
| +1.30% | -5.37% | +2.84% | +8.34% | 13.12B | |
| -2.68% | -2.49% | -11.36% | -34.51% | 12.7B | |
| Average | +0.30% | +0.83% | +55.53% | +107.50% | 27.25B | |
| Weighted average by Cap. | +0.55% | +0.91% | +75.08% | +137.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.37M 67.2M 59.02M 54.89M 94.64M 6.47B 96.1M 652M 255M 3.18B 252M 247M 11B | 55.23M 73.69M 64.72M 60.19M 104M 7.1B 105M 715M 279M 3.49B 277M 271M 12.06B |
| Net income | -3.49M -4.66M -4.09M -3.81M -6.56M -449M -6.66M -45.19M -17.65M -221M -17.49M -17.11M -763M | -1.03M -1.37M -1.2M -1.12M -1.93M -132M -1.96M -13.27M -5.18M -64.77M -5.14M -5.02M -224M |
| Net Debt | -8.49M -11.33M -9.95M -9.25M -15.96M -1.09B -16.2M -110M -42.93M -536M -42.53M -41.61M -1.85B | -9.93M -13.25M -11.64M -10.83M -18.66M -1.28B -18.95M -129M -50.22M -627M -49.75M -48.68M -2.17B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
